Colgate-Palmolive (NYSE:CL) Shares Sold by USA Financial Formulas

USA Financial Formulas lowered its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 84.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,334 shares of the company's stock after selling 12,792 shares during the period. USA Financial Formulas' holdings in Colgate-Palmolive were worth $212,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. D Orazio & Associates Inc. increased its position in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after purchasing an additional 108 shares during the period. Fiducient Advisors LLC grew its holdings in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock worth $232,000 after acquiring an additional 110 shares during the period. Sequoia Financial Advisors LLC raised its position in Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock worth $2,117,000 after acquiring an additional 113 shares in the last quarter. Great Waters Wealth Management lifted its holdings in Colgate-Palmolive by 1.5% in the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company's stock valued at $796,000 after acquiring an additional 117 shares during the period. Finally, Waldron Private Wealth LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company's stock worth $585,000 after purchasing an additional 118 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.2 %

CL stock traded up $0.18 during trading on Friday, reaching $88.74. 2,572,092 shares of the stock traded hands, compared to its average volume of 4,780,353. The firm has a market capitalization of $72.50 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business's 50 day moving average price is $92.32 and its 200-day moving average price is $97.85. Colgate-Palmolive has a 52-week low of $79.69 and a 52-week high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a report on Thursday. UBS Group dropped their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating for the company in a report on Thursday. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a research report on Friday. Barclays lowered their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and an average target price of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.